Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on September 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

AZELASTINE HYDROCHLORI

Closed
SPE2DP-26-T-5280Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411
New
Federal
Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Solicitation # 75N98027R00020
The National Center for Advancing Translational Sciences within the National Institutes of Health has issued a Sources Sought notice for an IDIQ contract focused on reagent generation for bioanalytical method development on biologics therapeutics. The primary objective is to identify qualified sources capable of generating and delivering high-affinity, specific anti-drug antibodies, including neutralizing antibodies and antibodies against carriers or gene-of-interest protein products. These reagents will support the quantification of novel biologic drugs in biological matrices such as plasma, serum, and tissue homogenates. The anticipated scope includes the production of polyclonal and monoclonal antibodies, specificity characterization, and the delivery of purified antibodies at an estimated scale of 10 to 50 mg per reagent. The required performance standards are rigorous, demanding adherence to US FDA current Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice, as well as ICH and ISO regulations. Contractors must maintain a comprehensive Quality Management Plan and an independent Quality Assurance Unit to ensure all products meet strict quality requirements. Additional requirements include the development of standard operating procedures for packaging and shipping, the maintenance of secure facilities with restricted access, and the implementation of contingency plans for catastrophic events. The anticipated period of performance for this effort is ten years. Interested respondents must be registered in the System for Award Management and provide a capability statement under NAICS code 325411 by November 30, 2026.
National Institutes Of Health Nida

POSTED

about 14 hours ago

DEADLINE

in 14 days
NAICS: 325411
New
DIBBS
ANALGESIC GEL, TOPICAL
Solicitation # SPE2DP-27-T-0371
Solicitation SPE2DP-27-T-0371 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Biofreeze topical analgesic gel. The requirement consists of four units of colorless gel containing 5% Menthol USP in 4 oz (118ml) tubes, intended for use by adults and children aged two years and older. The product is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months and must be stored in a cool, dry place between 20-25 C (68-77 F) away from direct sunlight. Due to its flammable nature, the gel must be kept away from excessive heat or open flames. Delivery is specified as FOB Destination to the 0024 QM Co Composite Suppl at Joint Base Lewis MCCH, WA, with a required delivery date of November 16, 2026, and a delivery window of 20 days. Packaging must follow MIL-STD-2073-1E and RP001 DLA packaging requirements, utilizing suitable sealed unit containers and commercial exterior shipping containers. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including requirements for equal opportunity for workers with disabilities, safeguarding covered defense information, and compliance with the Buy American Act and Berry Amendment. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 7 days
NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINE
Solicitation # SPE2DP-27-T-0291
This procurement, solicitation SPE2DP-27-T-0291, is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Ketorolac Tromethamine Injection. The requirement is for 10 packages of USP 15 mg per ml solution provided in pre-filled syringes, identified by NSN 6505-01-666-2156. The product is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months. Delivery is required FOB Destination to the 1AD Sustainment Brigade SSA at Fort Bliss, Texas, with a required delivery date of November 13, 2026, and a delivery timeline of 20 days. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking, although MIL-STD-129 remains applicable for general shipment and storage. Packaging must be commercial and include suitable sealed unit containers, with specific requirements for hazardous materials under FED-STD-313 and TQ requirement IP025. Suppliers must submit Safety Data Sheets and Hazard Communication Standard labels for review prior to award. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic preferences, and small business representations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 1 day

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5280, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of Azelastine Hydrochloride Nasal Solution 0.1% nasal spray. The requirement is for 6 bottles of the solution, with each spray delivering 137 micrograms. The product must be stored upright at temperatures between 20 C to 25 C and protected from freezing. Delivery is required within 20 days after order to the 0548 CS BN CO A Composite at Fort Drum, New York, with shipping terms set as FOB Destination. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires commercial packaging in sealed unit containers to prevent damage. All quotes must be submitted via the DIBBS system by October 5, 2026. Key regulatory requirements include compliance with the Buy American Act for quotes above the micro-purchase threshold, the Hazard Communication Standard for hazardous material labeling, and the use of the Wide Area WorkFlow system for invoicing. Inspection and acceptance will occur at the destination per FAR 52.246-2.

General Info

DLA seeks quotes for 6 Azelastine nasal spray bottles delivered to Fort Drum.

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

BLDG 4486 CAMP SWIFT ROAD, FORT DRUM, NY, 13602-5000, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this first18 pages · rfq
High

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • ISOPROPYL ALCOHOLOpen now, due in 7 days
  • Reagent Generation for Bioanalytical Method Development on Biologics TherapeuticsOpen now, due in 14 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
AZELASTINE HYDROCHLORIDE NASAL SOLUTION
AZELASTINE HYDROCHL
AZELASTINE HYDROCHLORIDE NASAL SOLUTION 0.1% (NASAL SPRAY), 137
MICROGRAMS (MCG) PER SPRAY
STORE UPRIGHT AT 20 C TO 25 C (68 F TO 77 F) [SEE USP CONTROLLED ROOM
TEMPERATURE]. PROTECT FROM FREEZING;
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
AVKARE LLC 4QGW8 P/N NDC42291-0094-30 APOTEX CORP. 4PX51 P/N NDC60505-0833-05 AMNEAL PHARMACEUTICALS OF NEW YORK, LLC 557X3 P/N NDC65162-0676-84
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018516869 0001 BT 6.000
NSN/MATERIAL:6505017252847
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
SPE2DP-26-T-5280
SECTION B
PR: 7018516869 PRLI: 0001 CONT’D
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W810DR
0548 CS BN CO A COMPOSITE
AWCF SSF
BLDG 4486 CAMP SWIFT ROAD
FORT DRUM NY 13602-5000
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W810DR
0548 CS BN CO A COMPOSITE
AWCF SSF
SPE2DP-26-T-5280
SECTION B
PR: 7018516869 PRLI: 0001 CONT’D
BLDG 4486 CAMP SWIFT ROAD
FORT DRUM NY 13602-5000
US
MARKFOR
W810DR
0548 CS BN CO A COMPOSITE
AWCF SSF
BLDG 4486 CAMP SWIFT ROAD
FORT DRUM NY 13602-5000
US
M/F: (TCN) W810DR62610429
RDD: 275
PROJ: TP 2
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/29/2026
SPE2DP-26-T-5280 NSN/Part Number: 6505-01-725-2847 Quantity: 6 BT Purchase Request: 7018516869QTY: 6 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS